The Pharma Data

MARCH 9, 2021

New data from 10 studies will be presented by Eli Lilly and Company (NYSE: LLY) at the upcoming virtual International Conference on Alzheimer’s & Parkinson Diseases 2021 (AD/PD 2021), March 9-14, 2021.

Disease 40

Disease International Research Therapies 40

The Pharma Data

DECEMBER 8, 2020

9, 2020 /PRNewswire/ — The members of the Nomination Committee for BioInvent International AB :s (publ) (“BioInvent) Annual General Meeting in 2021 have now been appointed. The Annual General Meeting will be held on April 29, 2021 in Lund, Sweden. LUND, Sweden , Dec. Chairman of the Nomination Committee.

Clinical Trials 40

Clinical Trials Licensing Licensing International 40

Drug Discovery World

JANUARY 31, 2024

Onward Therapeutics licensed the exclusive worldwide rights of development, manufacture, and commercialisation of OT-A201 from Biomunex Pharmaceuticals, a biopharmaceutical company discovering and developing bi- and multi-specific antibodies, in February 2021. We are enthusiastic to test OT-A201 for the first time in patients.

Clinical Trials 130

Clinical Trials Trials Treatment Pharmacokinetics 130

The Pharma Data

MAY 2, 2021

Holzkirchen, May 3, 2021 – Sandoz, a Novartis division, today announced progress in the late-stage clinical development program for its proposed biosimilar aflibercept. Sandoz will begin enrolling the first patient in MYLIGHT, a clinical Phase III confirmatory efficacy and safety study, shortly 1. Accessed April 2021].

Biosimilars 40

Biosimilars Clinical Development Production Government 40

Drug Discovery World

MAY 3, 2023

Adcendo, a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) for the treatment of cancers with a high unmet medical need, has completed a successful Series A extension financing round, raising a further €31 million, following the €51 million Series A financing in April 2021.

Licensing 130

Licensing Licensing Clinical Development Therapies 130

Drug Discovery World

APRIL 25, 2023

Pre-clinical research investigating the CAR-T cell therapy demonstrated an ability to potently suppress HIV and eliminate HIV-expressing cells in vitro and in animal models. In 2021 there were an estimated 1.5 Currently, there are approximately 38 million people living with HIV around the world.

Research 130

Research Clinical Trials Therapies Clinical Development 130

Drug Discovery World

JUNE 26, 2023

Now, there are many mRNA-based therapeutics in clinical development and mRNA cancer vaccines have been promised by 2030. In rare diseases, Moderna has several mRNA therapeutics in clinical development, including one in Phase II, a treatment for Propionic acidemia (PA), for which the company recently announced encouraging trial results.

Vaccine 130

Vaccine Virus Clinical Trials Trials 130

The Pharma Data

APRIL 8, 2021

today announced that new data for its approved and investigational medicines for the treatment of neurological disorders will be presented at the 73rd American Academy of Neurology (AAN) Annual Meeting being held virtually April 17-22, 2021. P15: MS Clinical Trials and Therapeutics. Spinal Muscular Atrophy (SMA). Abstract Title.

Clinical Trials 52

Clinical Trials Trials Disease Nurses 52

The Pharma Data

AUGUST 3, 2021

In the first half of 2021, Boehringer Ingelheim has supplied more humans and animals worldwide with innovative medicines than ever before. Our strong R&D pipeline has made further, decisive progress in the first half of 2021. In the first half of 2021, Boehringer Ingelheim generated strong net sales of around 2.3

Research 52

Research Clinical Trials Treatment Production 52

Cytel

OCTOBER 27, 2023

Since its launch in 2021, Project Optimus has been reforming the dose optimization and dose selection paradigm in oncology drug development. Most of these post-approval changes have been overall decreases in dose. To address this challenge, the FDA Oncology Center of Excellence initiated Project Optimus.

Clinical Trials 64

Clinical Trials Trials Clinical Pharmacology Clinical Development 64

The Pharma Data

JULY 12, 2021

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the presentation of data from the company’s HIV clinical development program at the 11th International AIDS Society Conference on HIV Science (IAS 2021) from July 18-21. Late Breaking Oral Presentation OALC01LB03. Abstract 804. Paudel et al.

Pharmacokinetics 52

Pharmacokinetics Clinical Trials Trials Treatment 52

The Pharma Data

JANUARY 20, 2021

20, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. The offering is expected to close on or about January 25, 2021, subject to satisfaction of customary closing conditions. SOUTH SAN FRANCISCO, Calif., Morgan Securities LLC, Cowen and Company, LLC and Piper Sandler are acting as joint bookrunning managers for the offering.

Clinical Development 40

Clinical Development Therapies Science Drugs 40

Drug Discovery World

DECEMBER 7, 2022

If clinical research into collagen maintains this momentum, we can expect to see innovations in wound healing and bone care making their way to patients in the coming years.”. In 2021, the global collagen market was valued at $9.75 billion USD, and is expected to grow to $16.7 billion by 2028.

Clinical Trials 130

Clinical Trials Trials Clinical Research Clinical Development 130

The Pharma Data

DECEMBER 21, 2020

UBX1325 is developed from BM-962, a Bcl-xL inhibiting compound licensed to UNITY by Ascentage Pharma for the treatment of age-related diseases. This progress in clinical development qualifies Ascentage Pharma for a milestone payment according to the terms of the licensing agreement. SUZHOU, China and ROCKVILLE, Md. ,

Clinical Development 40

Clinical Development Disease Treatment Licensing 40

The Pharma Data

SEPTEMBER 8, 2021

today announced that data reinforcing the potential of immunotherapies to impact clinical outcomes for patients will be featured at the European Society for Medical Oncology (ESMO) 2021 Virtual Congress from September 16-21. To date, the Opdivo clinical development program has treated more than 35,000 patients.

Research 52

Research Immune Response Treatment Trials 52

The Pharma Data

JANUARY 19, 2021

With this kind of a start, 2021 may be scorching. The company hopes to raise $140 million of common stock, which will be used to advance its clinical and earlier stage programs and for R&D, working capital and general corporate purposes. Last year was a record number of IPOs in the biotech industry, with 81 raising $13.5

Small Molecule 52

Small Molecule Laboratories Immune Response Trials 52

The Pharma Data

JANUARY 19, 2021

19, 2021 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. The offering is expected to close on January 22, 2021, subject to customary closing conditions. The company has advanced losmapimod to Phase 2 clinical development for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and Phase 3 for the treatment of COVID-19.

Small Molecule 40

Small Molecule Clinical Development Treatment Engineering 40

Drug Discovery World

MARCH 7, 2023

Dr Natalie Kenny, Founder and CEO, BioGrad In 2021, Dr Kenny won EVA’s Businesswoman of the Year award, The Business Desk top 50 City Region Leader for Liverpool and The Business Desk’s North West Investment Award. She was appointed as CEO of Novo Nordisk Pharmatech in 2021.

International 246

International Science Pharmaceuticals DNA 246

The Pharma Data

MARCH 8, 2021

We are delighted to share our early data at CROI 2021 supporting the potential for a once-yearly dosing regimen for islatravir using a subdermal implant,” said Dr. Joan Butterton, vice president, global clinical development, infectious diseases, Merck Research Laboratories. “We

Trials 52

Trials Clinical Trials Pharmacokinetics Research Laboratories 52

The Pharma Data

AUGUST 6, 2020

Under the pact, AZ will transfer the vaccine’s technology to BioKangtai, which will in return reserve enough capacity to make at least 100 million doses of the shot by the end of 2020 and expand to 200 million doses per year by the end of 2021. China has several home-grown COVID-19 vaccines in clinical development.

Vaccine 52

Vaccine Licensing Licensing Immune Response 52

KIF1A

MARCH 16, 2024

billion people were affected by neurological disorders in 2021, making them a leading cause of disability worldwide. While genetic disorders like KAND make up only a small part of this number, this represents the need for increased investment in neuroscience research and clinical development.

Disease 105

Disease Clinical Development Research Treatment 105

The Pharma Data

JULY 23, 2021

(Nasdaq: BIIB) today announced it will share multiple oral and poster presentations from its Alzheimer’s disease clinical development portfolio at the Alzheimer’s Association International Conference (AAIC), which will be held in Denver, Colorado and online July 26-30, 2021.

International 52

International Disease Clinical Trials Trials 52

The Pharma Data

JANUARY 14, 2021

15, 2021 /PRNewswire/ — Calliditas Therapeutics AB (publ) (“Calliditas”) (Nasdaq OMX – CALTX) (NASDAQ – CALT) today announced the program for the upcoming virtual R&D Day for investors, analysts and journalists on January 20, 2021 , which will take place between 1pm and 5pm CET. STOCKHOLM , Jan.

Clinical Trials 40

Clinical Trials Hospitals Disease International 40

Drug Discovery World

APRIL 14, 2023

Dr Schon is applying his broad expertise from lead discovery to manufacture in order to progress differentiated, safe and developable bi-specific therapeutic ADC candidates to clinical development. Biography Oliver Schon, PhD, has been VP, R&D at BiVictriX Therapeutics since September 2021.

Drug Development 130

Drug Development Drugs Clinical Trials Therapies 130

Drug Discovery World

JULY 3, 2024

OECD data places Switzerland second in the world for biotechnology R&D intensity 1 , and in 2021, the country had the seventh largest share of the global biotech market 2. Such investments contribute to the emergence of numerous health technologies being developed into innovative products.”

Drugs 130

Drugs Clinical Trials Science Therapies 130

The Pharma Data

JANUARY 20, 2021

20, 2021 /PRNewswire/ — INOVIO Pharmaceuticals, Inc. The offering is expected to close on or about January 25, 2021 , subject to customary closing conditions. PLYMOUTH MEETING, Pa. , Gross proceeds to INOVIO from the offering are expected to be approximately $150.5 All of the shares are being sold by INOVIO.

DNA 40

DNA Immune Response Disease Clinical Trials 40

Drug Discovery World

JULY 2, 2024

OECD data places Switzerland second in the world for biotechnology R&D intensity 1 , and in 2021, the country had the seventh largest share of the global biotech market 2. The centre currently has 58 pharma/biotech assets that are in pre-clinical development, alongside 29 that are being tested in clinical trials.

Science 147

Science Drugs Clinical Trials Licensing 147

The Pharma Data

APRIL 6, 2021

Bayer will present new research across its oncology portfolio at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021 , taking place over two weeks on April 10-15 and May 17-21, 2021. o Abstract CT001; April 10, 11:30am EDT.

Research 52

Research Small Molecule Treatment Clinical Trials 52

Drug Discovery World

SEPTEMBER 6, 2022

As researchers and developers work to transform the way we treat diseases, cell and gene therapies will continue to be the centre of innovation in the coming years. . Record breaking investments in 2021 fuel an industry on fire . billion raised. However, the question remains as to whether this will continue in 2022.

Therapies 130

Therapies Clinical Trials Production Disease 130

Drug Discovery World

NOVEMBER 4, 2022

Key to Exscientia’s AI approach is using the knowledge of the observed human antibody space to optimise biologics for clinical development. Bioinformatics 2021 . The binding site of the antibody consists of two chains (heavy and light). References . Abanades et al.

Small Molecule 130

Small Molecule Bioinformatics Laboratories Engineering 130

The Pharma Data

JANUARY 18, 2021

18, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. The fireside chat is scheduled to take place on Wednesday, January 20, 2021 at 2:30 PM ET. The fireside chat is scheduled to take place on Wednesday, January 20, 2021 at 2:30 PM ET. © 2021 Sorrento Therapeutics, Inc. SAN DIEGO, Jan.

Small Molecule 40

Small Molecule Clinical Trials Trials Therapies 40

Drug Discovery World

APRIL 29, 2024

He holds a PhD in Chemistry for early work on antibody drug conjugates in 1987 and was awarded the Bioprocessing Lifetime Achievement Award in 2021. Dr Uwe Gottschalk, Chairman of the Board of Directors, Cellevate: Dr Gottschalk currently serves as an Operating Partner at Keensight Capital.

Drugs 130

Drugs Small Molecule Bioinformatics Pharmaceuticals 130

The Pharma Data

APRIL 11, 2021

The data were presented at the 2021 American Association for Cancer Research (AACR) Annual Meeting, held virtually April 10-15, 2021. was approved by the European Commission in February 2021. The Phase 1/2 LIBRETTO-001 trial is the largest clinical trial of patients with RET -driven cancers treated with a RET inhibitor.

Research 52

Research Therapies Treatment Trials 52

The Pharma Data

JULY 21, 2021

These data were shared as a late-breaking oral presentation during the virtual 11 th International AIDS Society Conference on HIV Science (IAS 2021) and are a follow-up to the interim analysis that was presented earlier this year at the virtual 2021 HIV Research for Prevention Conference (HIVR4P 2021).

Clinical Trials 52

Clinical Trials Pharmacokinetics Trials International 52

Drug Target Review

AUGUST 24, 2023

She joined the company in November 2018 with more than 10 years of experience in drug discovery and non-clinical development of immunomodulatory drugs in the immuno-oncology space. 2021 Jul 6;120(13):2644-56. 2021 Dec 1;9(12):1425-38. 2021 Jun 17;12:685370. 2021 Nov 1;41. Biophysical Journal.

Treatment 98

Treatment Therapies Clinical Development Cell Biology 98

The Pharma Data

MARCH 17, 2021

Gallen International Breast Cancer Conference Poster Awards 2021. Gallen will be published in a supplement issue of The Breast, available on March 17, 2021. Available on-demand on March 10, 2021. Gallen International Breast Cancer Conference Poster Awards 2021. Available on-demand on March 10, 2021.

Trials 52

Trials Therapies Treatment Pharmacokinetics 52

Drug Discovery World

JULY 11, 2022

2021, February 23). " September 14, 2021.Pharma's " July21, 2021. Methods& clinical development, 21,524–529. Krishnan, M., &Davies, C (2021). "UnchartedTerritory: "UnchartedTerritory: Top Challenges Facing Gene Therapy Development."

Therapies 130

Therapies Clinical Trials Production Trials 130